Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-08
DOI
10.1038/s41541-019-0121-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever
- (2018) So Jung An et al. VACCINE
- Outer membrane vesicles for vaccination and targeted drug delivery
- (2018) Sihan Wang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
- (2018) Vinay Menon et al. Frontiers in Immunology
- Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission
- (2018) Gaspar E. Canepa et al. npj Vaccines
- Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
- (2018) Issaka Sagara et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
- (2018) Jessica A. Chichester et al. VACCINE
- Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine
- (2017) Michael Theisen et al. Expert Review of Vaccines
- Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine
- (2017) Susheel K. Singh et al. Microbial Cell Factories
- Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity
- (2017) Puthupparampil V. Scaria et al. PLoS One
- Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display
- (2017) Susheel K. Singh et al. VACCINE
- Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation
- (2017) Dibyadyuti Datta et al. VACCINE
- Adjuvant and carrier protein-dependent T-cell priming promotes a robust antibody response against the Plasmodium falciparum Pfs25 vaccine candidate
- (2017) Andrea J. Radtke et al. Scientific Reports
- Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of thePlasmodium falciparumSexual Stage Protein Pfs230
- (2016) Nicholas J. MacDonald et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Method for Producing Protein Nanoparticles with Applications in Vaccines
- (2016) David S. Jones et al. PLoS One
- Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine
- (2016) Donald J. Chabot et al. VACCINE
- Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
- (2016) Kawsar R. Talaat et al. PLoS One
- Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
- (2016) Yuanyuan Li et al. Scientific Reports
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles
- (2015) Rajesh Kumar et al. VACCINE
- Recent advances in recombinant protein-based malaria vaccines
- (2015) Simon J. Draper et al. VACCINE
- Outer membrane vesicles as platform vaccine technology
- (2015) Leo van der Pol et al. Biotechnology Journal
- A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
- (2013) Miguel O’Ryan et al. DRUGS
- A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
- (2013) R. Mark Jones et al. PLoS One
- The Human Malaria Parasite Pfs47 Gene Mediates Evasion of the Mosquito Immune System
- (2013) A. Molina-Cruz et al. SCIENCE
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant Vaccine
- (2012) D. K. Mathias et al. INFECTION AND IMMUNITY
- Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex
- (2012) Craig Przysiecki et al. Frontiers in Cellular and Infection Microbiology
- Outer Membrane Protein Complex of Meningococcus Enhances the Antipolysaccharide Antibody Response to Pneumococcal Polysaccharide–CRM197Conjugate Vaccine
- (2011) Zengzu Lai et al. Clinical and Vaccine Immunology
- N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity
- (2011) Mayumi Tachibana et al. Clinical and Vaccine Immunology
- A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum
- (2011) Christine E. Farrance et al. Clinical and Vaccine Immunology
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
- (2009) Johan Holst et al. VACCINE
- Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure
- (2008) Feng Qian et al. MICROBES AND INFECTION
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started